ADD ANYTHING HERE OR JUST REMOVE IT…
  • About Us
    • Scientific Advisory
  • Technology
  • Products
  • Clinical Solutions
    • Cardiothoracic Surgery
    • Vascular Surgery
    • Urology Surgery
    • General Surgery
  • Distributor
  • Resources
    • Events
    • News
    • Publications
  • Contact Us
Let's Connect +1 (949) 670 0403
Tisgenx
Menu
  • About Us
    • Scientific Advisory
  • Technology
  • Products
  • Clinical Solutions
    • Cardiothoracic Surgery
    • Vascular Surgery
    • Urology Surgery
    • General Surgery
  • Distributor
  • Resources
    • Events
    • News
    • Publications
  • Contact Us

Monthly Archives: August 2025

Home2025AugustPage 5
General, Tisgenx

Pseudoaneurysm formation at the right ventricular anastomosis of a pulmonary homograft following tetralogy of Fallot repair: a rare late complication

Posted by author-avatar admin
August 6, 2025
0
We report a 7-year-old boy with tetralogy of Fallot who developed a right ventricular pseudoaneurysm one year after right ventricular o...
Continue reading
General

Animal model of a bovine pericardial patch for thoracoabdominal aortic aneurysms: step by step

Posted by author-avatar admin
August 5, 2025
0
CONCLUSIONS: The experimental model of TAA using a bovine pericardial patch and a sequential clamping technique provided a stable and reliable platform that remains stable and patent for up to 4 weeks. This model can be extremely valuable for assessing new endovascular therapy options in living organisms.
Continue reading
General

NSUN2 inhibits NCOA4 expression to alleviate ferroptosis and inflammation in sepsis-induced myocardial injury in a m5C manner

Posted by author-avatar admin
August 3, 2025
0
Sepsis-induced myocardial injury (SIMI) leads to high morbidity and mortality. The 5-methylcytosine (m5C) RNA methyltransferase NOL1/NOP2/SUN domain (NSUN)2 is a therapeutic target for many diseases. The purpose ...
Continue reading
General

NSUN2 inhibits NCOA4 expression to alleviate ferroptosis and inflammation in sepsis-induced myocardial injury in a m5C manner

Posted by author-avatar admin
August 1, 2025
0
Sepsis-induced myocardial injury (SIMI) leads to high morbidity and mortality. The 5-methylcytosine (m5C) RNA methyltransferase NOL1/NOP2/SUN domain (NSUN)2 is a therapeutic target for many diseases. The purpose ...
Continue reading
  • 1
  • 2
  • 3
  • 4
  • 5
Close

Recent Posts

  • Impact of the COVID-19 pandemic on admission trends, diagnosis patterns, and demographics of ischemic heart disease patients: a retrospective study
  • In Vivo Preclinical Testing of a Bridging Stent for Fenestrated Endovascular Repair Using a Dedicated Swine Pararenal Aneurysm Model
  • Managing the Giant: A Novel Approach in Orthotopic Heart Transplantation With Extreme Left Atrial Enlargement
  • Aortic and mitral valve repair in a child with rheumatic heart disease
  • Impact of the COVID-19 pandemic on admission trends, diagnosis patterns, and demographics of ischemic heart disease patients: a retrospective study

Recent Comments

  1. A WordPress Commenter on Hello world!

Archives

  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • July 2024
  • June 2024
  • May 2024
  • April 2024
  • March 2024
  • February 2024
  • January 2024
  • December 2023
  • November 2023
  • October 2023
  • September 2023
  • August 2023
  • July 2023
  • June 2023
  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022

Categories

  • Uncategorized
  • General
  • Tisgenx

Quick Links

  • About Us
  • Technology
  • Products
  • Distributor
  • Resources

Clinical Solutions

  • Cardiothoracic Surgery
  • Vascular Surgery
  • Urology Surgery
  • General Surgery

Resources

Brand Names

  • Events
  • News
  • Publications
  • Invengenx®
  • Vascugenx®
  • Urogenx®
  • Surgenx™

Contact Info

Address:

15615 Alton Parkway, Suite 450, Irvine, CA 92618

Phone:

+1 (949) 670-0403

Email:

info@tisgenx.com

Copyright © 2025 TisgenX. Privacy Policy. All Rights Reserved.
Close
  • About Us
    • Scientific Advisory
  • Technology
  • Products
  • Clinical Solutions
    • Cardiothoracic Surgery
    • Vascular Surgery
    • Urology Surgery
    • General Surgery
  • Distributor
  • Resources
    • Events
    • News
    • Publications
  • Contact Us
Shop
Sidebar